MAPK4
Basic information
Region (hg38): 18:50560087-50731826
Previous symbols: [ "PRKM4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAPK4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 52 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 52 | 2 | 0 |
Variants in MAPK4
This is a list of pathogenic ClinVar variants found in the MAPK4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-50663980-A-G | not specified | Uncertain significance (Jan 24, 2024) | ||
18-50663983-G-T | not specified | Uncertain significance (Oct 08, 2024) | ||
18-50664007-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
18-50664008-G-A | not specified | Uncertain significance (Aug 11, 2024) | ||
18-50664079-C-T | not specified | Uncertain significance (Sep 13, 2023) | ||
18-50664086-G-A | not specified | Uncertain significance (May 23, 2024) | ||
18-50664141-C-T | Likely benign (Jan 01, 2023) | |||
18-50664170-G-A | not specified | Uncertain significance (Nov 06, 2024) | ||
18-50664183-C-A | not specified | Uncertain significance (Apr 17, 2023) | ||
18-50664255-C-A | not specified | Uncertain significance (Mar 25, 2024) | ||
18-50664268-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
18-50664289-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
18-50664314-G-A | not specified | Uncertain significance (Aug 20, 2024) | ||
18-50664346-A-G | not specified | Uncertain significance (May 31, 2023) | ||
18-50664445-G-C | not specified | Uncertain significance (Mar 12, 2024) | ||
18-50664481-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
18-50715115-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
18-50715168-G-A | not specified | Uncertain significance (Jun 02, 2023) | ||
18-50721934-C-T | Likely benign (Jan 01, 2023) | |||
18-50721945-T-A | not specified | Uncertain significance (Oct 12, 2021) | ||
18-50721948-G-A | Likely benign (Jun 01, 2022) | |||
18-50721960-G-A | not specified | Uncertain significance (Aug 20, 2024) | ||
18-50722062-G-C | not specified | Uncertain significance (Apr 13, 2022) | ||
18-50722092-C-A | not specified | Uncertain significance (Oct 24, 2023) | ||
18-50726058-G-A | not specified | Uncertain significance (Oct 12, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAPK4 | protein_coding | protein_coding | ENST00000400384 | 5 | 171747 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.219 | 0.781 | 124899 | 0 | 10 | 124909 | 0.0000400 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.68 | 282 | 373 | 0.756 | 0.0000271 | 3798 |
Missense in Polyphen | 110 | 175.12 | 0.62814 | 1858 | ||
Synonymous | 0.0896 | 173 | 175 | 0.991 | 0.0000140 | 1174 |
Loss of Function | 3.13 | 5 | 20.2 | 0.248 | 0.00000105 | 224 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000935 | 0.0000930 |
Ashkenazi Jewish | 0.000102 | 0.0000993 |
East Asian | 0.0000556 | 0.0000555 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000530 | 0.0000529 |
Middle Eastern | 0.0000556 | 0.0000555 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Atypical MAPK protein. Phosphorylates microtubule- associated protein 2 (MAP2) and MAPKAPK5. The precise role of the complex formed with MAPKAPK5 is still unclear, but the complex follows a complex set of phosphorylation events: upon interaction with atypical MAPKAPK5, ERK4/MAPK4 is phosphorylated at Ser-186 and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK4/MAPK4. May promote entry in the cell cycle (By similarity). {ECO:0000250}.;
- Pathway
- IL-17 signaling pathway - Homo sapiens (human);VEGF Signaling Pathway;MicroRNAs in cardiomyocyte hypertrophy;Integrin-mediated Cell Adhesion;B Cell Receptor Signaling Pathway;Signal Transduction of S1P Receptor;TGF-beta Signaling Pathway;Angiopoietin Like Protein 8 Regulatory Pathway;ESC Pluripotency Pathways;Splicing factor NOVA regulated synaptic proteins;EGF-EGFR Signaling Pathway;Insulin Signaling;Regulation of Actin Cytoskeleton;Signal Transduction;MAPK6/MAPK4 signaling;MAPK family signaling cascades
(Consensus)
Recessive Scores
- pRec
- 0.0999
Intolerance Scores
- loftool
- 0.270
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.65
Haploinsufficiency Scores
- pHI
- 0.166
- hipred
- Y
- hipred_score
- 0.707
- ghis
- 0.526
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.411
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mapk4
- Phenotype
- growth/size/body region phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype;
Gene ontology
- Biological process
- MAPK cascade;protein phosphorylation;cell cycle;regulation of gene expression;intracellular signal transduction;cellular response to organic substance
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol
- Molecular function
- protein serine/threonine kinase activity;MAP kinase activity;protein binding;ATP binding;protein kinase binding;protein homodimerization activity;protein heterodimerization activity